MabPlex Launches New 2000-L Cell Culture Production Lines
The expansion gives the company diversified capacity running cell production lines featuring Sartorius-brand 2000-L disposable bioreactors and now GE-brand 2000-L single-use bioreactors.
MabPlex International, a contract development and manufacturing organization has started operations of two cell culture production lines of GE-brand 2000-L single-use bioreactors, the company announced on Feb. 25.
In addition, the company will further expand by adding two more production lines by the end of March 2020, which will feature Thermo-Fisher Scientific-brand 2000-L disposable bioreactors for clinical production. The company already runs Sartorius brand 2000-L disposable bioreactors.
"MabPlex offers one of the few globally integrated service platforms with high production capacity, something that is unique in our industry," said Yongjian Wu, PhD, chief operating officer, MabPlex USA, in a company press release.
The company has previously introduced a variety of international mainstream brand equipment for independent production lines to carry out multiple contract manufacturing processes designed to meet the varying needs of global customers. The company’s approach significantly reduces customer cost and shortens the drug-to-market cycle, according to the press release.
Source: MabPlex USA
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
